These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 20442512)

  • 1. Inflammation and pancreatic ductal adenocarcinoma: a potential scenario for novel drug targets.
    Uomo I; Miraglia S; Pastorello M
    JOP; 2010 May; 11(3):199-202. PubMed ID: 20442512
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel drug targets based on association between inflammation and pancreatic ductal adenocarcinoma.
    Saif MW
    JOP; 2010 Jul; 11(4):403-4; author reply 411. PubMed ID: 20601821
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
    Müerköster S; Arlt A; Sipos B; Witt M; Grossmann M; Klöppel G; Kalthoff H; Fölsch UR; Schäfer H
    Cancer Res; 2005 Feb; 65(4):1316-24. PubMed ID: 15735017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
    Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
    Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
    Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters.
    Adachi T; Tajima Y; Kuroki T; Mishima T; Kitasato A; Tsuneoka N; Kanematsu T
    Carcinogenesis; 2008 Apr; 29(4):830-3. PubMed ID: 18296437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin.
    Sclabas GM; Uwagawa T; Schmidt C; Hess KR; Evans DB; Abbruzzese JL; Chiao PJ
    Cancer; 2005 Jun; 103(12):2485-90. PubMed ID: 15861417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
    Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
    Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal and cystic tubulopapillary adenocarcinoma of the pancreas--a possible variant of intraductal tubular carcinoma.
    Königsrainer I; Glatzle J; Klöppel G; Königsrainer A; Wehrmann M
    Pancreas; 2008 Jan; 36(1):92-5. PubMed ID: 18192889
    [No Abstract]   [Full Text] [Related]  

  • 11. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pancreatic cancer: a major challenge in oncology].
    Fölsch UR; Schäfer H
    Med Klin (Munich); 2004 Apr; 99(4):183-4. PubMed ID: 15085287
    [No Abstract]   [Full Text] [Related]  

  • 13. PPAR-gamma knockout in pancreatic epithelial cells abolishes the inhibitory effect of rosiglitazone on caerulein-induced acute pancreatitis.
    Ivashchenko CY; Duan SZ; Usher MG; Mortensen RM
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G319-26. PubMed ID: 17463185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated solitary ducts (naked ducts) in adipose tissue: a specific but underappreciated finding of pancreatic adenocarcinoma and one of the potential reasons of understaging and high recurrence rate.
    Bandyopadhyay S; Basturk O; Coban I; Thirabanjasak D; Liang H; Altinel D; Adsay NV
    Am J Surg Pathol; 2009 Mar; 33(3):425-9. PubMed ID: 19092633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
    Andea A; Sarkar F; Adsay VN
    Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
    Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
    J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
    Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
    Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
    Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
    Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible electroporation: a novel pancreatic cancer therapy.
    Weiss MJ; Wolfgang CL
    Curr Probl Cancer; 2013; 37(5):262-5. PubMed ID: 24331180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.